FDA Grants Priority Review To Merck's SBLA For KEYTRUDA Monotherapy
Fresenius FY Sales EUR 33.5 Bln
Fresenius Medical Care Resolves Share Repurchase Program Of Up To EUR 1 Bln
Immune Pharmaceuticals Files For Chapter 11 Protection
Xellia Pharma Gets US FDA Approval For Premixed Vancomycin Injection
Indivior: The Lancet Publishes Phase 3 Results Of SUBLOCADET
Basilea FY Total Revenue Up 31% To CHF 133 Mln
Roche: FDA Grants Priority Review To Polatuzumab Vedotin With Rituximab